Cargando…

KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells

Development of chemoresistance remains a major hurdle for triple negative breast cancer treatment. Previous studies suggest that CD44+/CD24- cells, subpopulation of cancer stem cells with self-renewing and tumor-initiating capacities, are partly responsible for chemoresistance and therapeutic failur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Meng, Zhuang, Huiru, Xia, Rui, Gan, Lei, Wu, Yuantao, Ma, Junzhe, Sun, Yihui, Zhuang, Zhixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696167/ https://www.ncbi.nlm.nih.gov/pubmed/29190901 http://dx.doi.org/10.18632/oncotarget.20785

Ejemplares similares

Dexamethasone inhibits the proliferation of tumor cells
por: Wu, Yuantao, et al.
Publicado: (2019)

Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy
por: Thankamony, Archana P., et al.
Publicado: (2020)

380 The kinesin-like protein Kif11 is essential for the survival of TP53 mutant triple-negative breast cancer cells
por: Lanier, Amanda, et al.
Publicado: (2023)

Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2021)

KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers
por: Hu, Zhan-Dong, et al.
Publicado: (2021)

Chromosomally unstable tumor cells specifically require KIF18A for proliferation
por: Marquis, Carolyn, et al.
Publicado: (2021)

FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
por: Yu, Hongbo, et al.
Publicado: (2020)

KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma
por: Sun, Yue-Feng, et al.
Publicado: (2020)

Synergistic Effect of 3-Bromopyruvate in Combination with Rapamycin Impacted Neuroblastoma Metabolism by Inhibiting Autophagy
por: Gan, Lei, et al.
Publicado: (2020)

Prognostic Impact and Functional Annotations of KIF11 and KIF14 Expression in Patients with Colorectal Cancer
por: Neska-Długosz, Izabela, et al.
Publicado: (2021)

ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line
por: Hwang, Eunjoo, et al.
Publicado: (2018)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Martin, Miguel, et al.
Publicado: (2021)

Identification by Comprehensive Bioinformatics Analysis of KIF15 as a Candidate Risk Gene for Triple-Negative Breast Cancer
por: Sheng, Jiayu, et al.
Publicado: (2020)

KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation
por: Li, Xiao-Long, et al.
Publicado: (2019)

An interphase pool of KIF11 localizes at the basal bodies of primary cilia and a reduction in KIF11 expression alters cilia dynamics
por: Zalenski, Abigail A., et al.
Publicado: (2020)

KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer
por: Wei, Dang, et al.
Publicado: (2021)

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2017)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

In Vitro and In Vivo Effects of Docetaxel and Dasatinib in Triple-Negative Breast Cancer: A Research Study
por: Passos, Ioannis D, et al.
Publicado: (2023)

Identification of KIF11 as a Novel Target in Meningioma
por: Jungwirth, Gerhard, et al.
Publicado: (2019)

circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors
por: Terribas, Ernest, et al.
Publicado: (2020)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020)

Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles
por: Chen, Rujing, et al.
Publicado: (2021)

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
por: Zong, Beige, et al.
Publicado: (2021)

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
por: Zong, Beige, et al.
Publicado: (2021)

Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
por: Jeon, Ye-Won, et al.
Publicado: (2022)

KIF11 microdeletion is associated with microcephaly, chorioretinopathy and intellectual disability
por: Malvezzi, João VM, et al.
Publicado: (2018)

Update on the Phenotypic and Genotypic Spectrum of KIF11-Related Retinopathy
por: Wang, You, et al.
Publicado: (2022)

KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC
por: Cheng, Chunxia, et al.
Publicado: (2020)

MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
por: Wang, Cheng, et al.
Publicado: (2019)

Hedgehog-induced ciliary trafficking of kinesin-4 motor KIF7 requires intraflagellar transport but not KIF7’s microtubule binding
por: Yue, Yang, et al.
Publicado: (2022)

A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer
por: Abdelmaksoud, Bader A, et al.
Publicado: (2020)

TH1902, a new docetaxel‐peptide conjugate for the treatment of sortilin‐positive triple‐negative breast cancer
por: Demeule, Michel, et al.
Publicado: (2021)

SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
por: Choi, Yu-Jeong, et al.
Publicado: (2022)

Kinesin Family of Proteins Kif11 and Kif21B Act as Inhibitory Constraints of Excitatory Synaptic Transmission Through Distinct Mechanisms
por: Swarnkar, Supriya, et al.
Publicado: (2018)

KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment
por: Han, Yue, et al.
Publicado: (2022)

Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer
por: Ma, Ji, et al.
Publicado: (2020)

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial
por: Li, Junjie, et al.
Publicado: (2020)

The efficacy of betulinic acid in triple-negative breast cancer
por: Weber, Daniel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cqme2okvjrup284etbg4tnbtjt